Catheter Precision, Inc. Research and Development Expense
Catheter Precision, Inc. (VTAK) reported Research and Development Expense of $272.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-03-31
- Catheter Precision, Inc. research and development expense for the quarter ending 2024-12-31 was $91.00K.
- Catheter Precision, Inc. research and development expense for the quarter ending 2024-09-30 was $63.00K, a 43.75% decline year-over-year.
- Catheter Precision, Inc. research and development expense for the quarter ending 2024-06-30 was $81.00K, a 39.55% decline year-over-year.
- Catheter Precision, Inc. research and development expense for the quarter ending 2024-03-31 was $37.00K, a 84.58% decline year-over-year.
- Catheter Precision, Inc. research and development expense for fiscal 2024 was $272.00K, a 42.74% decline from fiscal 2023.
- Catheter Precision, Inc. research and development expense for fiscal 2023 was $475.00K, a 92.57% decline from fiscal 2022.
- Catheter Precision, Inc. research and development expense for fiscal 2022 was $6.39M, a 47.83% decline from fiscal 2021.
- Catheter Precision, Inc. research and development expense for fiscal 2021 was $12.25M, a 36.83% increase from fiscal 2020.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $154.00K derived: sum of 2 quarters · filed 2025-03-31 | $235.00K derived: sum of 3 quarters · filed 2025-03-31 | $272.00K 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | $63.00K 10-Q · filed 2024-11-14 | $144.00K derived: sum of 2 quarters · filed 2024-11-14 | $181.00K 10-Q · filed 2024-11-14 | $170.00K derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2024-06-30 | $81.00K 10-Q · filed 2024-08-14 | $118.00K 10-Q · filed 2024-08-14 | $107.00K derived: sum of 3 quarters · filed 2025-03-31 | $219.00K derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2024-03-31 | $37.00K 10-Q · filed 2024-05-06 | $26.00K derived: sum of 2 quarters · filed 2025-03-31 | $138.00K derived: sum of 3 quarters · filed 2025-03-31 | $272.00K derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2023-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $101.00K derived: sum of 2 quarters · filed 2025-03-31 | $235.00K derived: sum of 3 quarters · filed 2025-03-31 | $475.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $112.00K 10-Q · filed 2024-11-14 | $246.00K derived: sum of 2 quarters · filed 2024-11-14 | $486.00K 10-Q · filed 2024-11-14 | $640.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $134.00K 10-Q · filed 2024-08-14 | $374.00K 10-Q · filed 2024-08-14 | $528.00K derived: sum of 3 quarters · filed 2024-08-14 | $1.25M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $240.00K 10-Q · filed 2024-05-06 | $394.00K derived: sum of 2 quarters · filed 2024-05-06 | $1.12M derived: sum of 3 quarters · filed 2024-05-06 | $3.52M derived: sum of 4 quarters · filed 2024-05-06 | ||||
| 2022-12-31 | $154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $881.00K derived: sum of 2 quarters · filed 2024-04-01 | $3.28M derived: sum of 3 quarters · filed 2024-04-01 | $6.39M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $727.00K 10-Q · filed 2023-12-21 | $3.12M derived: sum of 2 quarters · filed 2023-12-21 | $6.24M 10-Q · filed 2023-12-21 | $9.97M derived: sum of 4 quarters · filed 2023-12-21 | ||||
| 2022-06-30 | $2.40M 10-Q · filed 2023-12-15 | $5.51M 10-Q · filed 2023-12-15 | $9.24M derived: sum of 3 quarters · filed 2023-12-15 | $12.19M derived: sum of 4 quarters · filed 2023-12-15 | ||||
| 2022-03-31 | $3.12M 10-Q · filed 2023-06-02 | $6.85M derived: sum of 2 quarters · filed 2023-06-02 | $9.79M derived: sum of 3 quarters · filed 2023-06-02 | $12.62M derived: sum of 4 quarters · filed 2023-06-02 | ||||
| 2021-12-31 | $3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $6.67M derived: sum of 2 quarters · filed 2023-03-28 | $9.50M derived: sum of 3 quarters · filed 2023-03-28 | $12.25M 10-K · filed 2023-03-28 | ||||
| 2021-09-30 | $2.94M 10-Q · filed 2022-11-14 | $5.77M derived: sum of 2 quarters · filed 2022-11-14 | $8.52M 10-Q · filed 2022-11-14 | $11.94M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $2.83M 10-Q · filed 2022-08-16 | $3.02M 10-Q · filed 2021-08-11 | $5.58M 10-Q · filed 2022-08-16 | $5.83M 10-Q · filed 2021-08-11 | $9.00M derived: sum of 3 quarters · filed 2022-08-16 | $11.31M derived: sum of 4 quarters · filed 2022-08-16 | ||
| 2021-03-31 | $2.75M 10-Q · filed 2022-05-16 | $2.82M 10-Q · filed 2021-05-12 | $6.17M derived: sum of 2 quarters · filed 2022-05-16 | $8.48M derived: sum of 3 quarters · filed 2022-05-16 | $10.44M derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $5.73M derived: sum of 2 quarters · filed 2022-03-24 | $7.69M derived: sum of 3 quarters · filed 2022-03-24 | $8.96M 10-K · filed 2022-03-24 | $9.01M 10-K · filed 2021-03-17 | |||
| 2020-09-30 | $2.31M 10-Q · filed 2021-11-15 | $2.33M 10-Q · filed 2020-11-16 | $4.26M derived: sum of 2 quarters · filed 2021-11-15 | $5.53M 10-Q · filed 2021-11-15 | $5.58M 10-Q · filed 2020-11-16 | $6.40M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $1.95M 10-Q · filed 2021-08-11 | $3.25M 10-Q · filed 2021-08-11 | $4.09M derived: sum of 3 quarters · filed 2021-08-11 | $5.27M derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | $1.29M 10-Q · filed 2021-05-12 | $2.13M derived: sum of 2 quarters · filed 2021-05-12 | $3.31M derived: sum of 3 quarters · filed 2021-05-12 | $4.29M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $838.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $2.02M derived: sum of 2 quarters · filed 2021-03-17 | $3.00M derived: sum of 3 quarters · filed 2021-03-17 | $4.53M 10-K · filed 2021-03-17 | ||||
| 2019-09-30 | $1.18M 10-Q · filed 2020-11-16 | $2.16M derived: sum of 2 quarters · filed 2020-11-16 | $3.69M 10-Q · filed 2020-11-16 | $4.94M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $979.00K 10-Q · filed 2020-08-11 | $2.51M 10-Q · filed 2020-08-11 | $3.75M derived: sum of 3 quarters · filed 2020-08-11 | $3.98M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $1.53M 10-Q · filed 2020-05-14 | $2.77M derived: sum of 2 quarters · filed 2020-05-14 | $3.00M derived: sum of 3 quarters · filed 2020-05-14 | $4.02M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $1.47M derived: sum of 2 quarters · filed 2020-03-11 | $2.49M derived: sum of 3 quarters · filed 2020-03-11 | $2.78M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $224.00K 10-Q · filed 2019-11-29 | $1.25M derived: sum of 2 quarters · filed 2019-11-29 | $1.53M 10-Q · filed 2019-11-29 | $1.89M derived: sum of 4 quarters · filed 2019-11-29 | ||||
| 2018-06-30 | $1.02M 10-Q · filed 2019-11-29 | $1.31M 10-Q · filed 2019-11-29 | $1.67M derived: sum of 3 quarters · filed 2019-11-29 | $2.08M derived: sum of 4 quarters · filed 2019-11-29 | ||||
| 2018-03-31 | $286.00K 10-Q · filed 2019-05-14 | $645.00K derived: sum of 2 quarters · filed 2019-05-14 | $1.06M derived: sum of 3 quarters · filed 2019-05-14 | |||||
| 2017-12-31 | $359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $772.00K derived: sum of 2 quarters · filed 2019-03-15 | $4.52M 10-K · filed 2019-03-15 | |||||
| 2017-09-30 | $413.00K 10-Q · filed 2018-11-14 | $4.16M 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |